DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Clinical Challenges: Long-Term Management of Thyroid Eye Disease
After thyroid eye disease (TED) is diagnosed and patients are started on initial treatment options, clinicians next have to focus on long-term management of the condition. “Long-term care for TED often requires a team of doctors,” said Terry J. Smith, MD, of Kellogg Eye Center at the University of Michigan in Ann Arbor, noting that the disease is both serious and progressive. Because up to half of patients with Graves’ disease typically go on to develop TED, long-term patient care should be co-managed by an endocrinologist and TED eye specialist, Smith told MedPage Today.
“Eye specialists managing TED can include oculoplastic surgeons, neuro-ophthalmologists, strabismus ophthalmologists, or optometrists who specialize in diagnosing and treating TED,” he said. “I recommend that all patients with Graves’ disease undergo a baseline comprehensive eye exam with an eye specialist and follow up with a specialist at the first sign of any eye symptoms.”
Related Content
-
News & MeetingsThyroid Awareness MonthJanuary is celebrated as Thyroid Awarene...
-
Evidence & EducationCancer Incidence and Mortality After Radioiodine Treatment for Hyperthyroidism: A Population-Based Cohort StudyBackground: Radioiodine is used increas...
-
Evidence & EducationStructural Brain Changes in Graves’ Hyperthyroidism may be of Autoimmune OriginIn Graves’ disease (GD), brain-derived...
-
Evidence & EducationRandomized Trial of a Short Course of Preoperative Potassium Iodide in Patients Undergoing Thyroidectomy for Graves&...Background: A short course of potassium...
-
People & PlacesAustralian Thyroid FoundationThe Australian Thyroid Foundation Ltd (A...
-
Videos & VisualsCoronavirus Preparedness for People with Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...
-
Evidence & EducationTreatment of Hyperthyroidism With Antithyroid Drugs Corrects Mild Neutropenia in Graves’ DiseaseContext: Neutropenia secondary to antit...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.